Lyproline insulin is a recombinant human insulin analogue and one of the three rapid-acting insulin analogues. Insulin lispro can be used in the research of hyperglycemia in diabetes.
Gestational diabetes mellitus (gestationaldiabetesmellitus) can lead to a variety of maternal and infant hazards such as fetal distress, hydramnios, severe cases, even cause miscarriage or stillbirth.…
Insulin glargine is a recombinant human insulin analogue, featuring stability, no peak, and a long duration of action. It has low solubility in neutral solutions but can be completely dissolved in aci…
Dete insulin is another new type of soluble long-acting human insulin analogue following insulin glargine. Developed by NovoNordisk, it was launched in Europe in 2004 and approved for the treatment of…
Trulicity (trade name: Trulicity), a long-acting GLP-1 analogue developed by Eli Lilly for one /w subcutaneous injection, was approved in the United States in September 2014 for the treatment of type …
Lisilacil is a glucagon-like peptide-1 (GLP-1) receptor agonist, and GLP-1 is a hormone that helps normalize blood glucose levels. The safety and efficacy of this drug were evaluated in 10 clinical tr…
Salmeterol Xinafoate is a long-acting β2-adrenergic receptor agonist with anti-inflammatory effects and is used for the treatment of asthma symptoms and symptoms of chronic obstructive pulmonary disea…
Salbutamolsulfate, also known as salbutamol sulfate, is the first highly selective β2 receptor agonist with a sufficiently strong bronchodilating effect. It is commonly used in clinical practice for t…
As a bronchodilator, it is used for the maintenance treatment of bronchospasm caused by chronic obstructive pulmonary disease (COPD). Indications: It is suitable for maintenance treatment of bronchosp…
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd. was established in 2012 and is dedicated to the development, production and sales of chemical products. We are a leading manufacturer and supplier of c…
Amycretin is a dual agonist of oral GLP-1 receptor and amylin receptor, having both GLP-1 agonizing effect and islet amyloid receptor agonizing effect. The origin of Amycretin can be traced back to 19…
Incestran is the world's first and only small interfering RNA (siRNA) drug used to reduce LDL-C. It can block the synthesis of PCSK9 protein from the source and also has certain advantages in the admi…
Ritalutide (LY3437943) is an agonist of glucose-dependent insulin-dependent polypeptide, glucagon-like peptide 1 and glucagon receptor. The dose-response relationship in terms of side effects, safety…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea